Search

everythinglearnresearchcommunity

for

Search:↓

Glypican-1 is important for hair follicle blood vessel growth and could be a target for treating hair loss.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

There may be a link between hair loss and heart disease in women, but more research is needed.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

PRP improves hair thickness for both genders, but only increases hair density in men.

Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.

Combining platelet-rich plasma with other treatments may improve hair growth in androgenetic alopecia.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

PRP shows promise in treating hair loss by promoting cell growth.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

Photobiomodulation increases hair density in 5 weeks for androgenetic alopecia.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

Blocking a key energy pathway in human hair follicles can trigger stress responses that stop cell growth.

Arginine deficiency hinders hair growth in androgenetic alopecia, but restoring it can promote hair regeneration.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Understanding alopecia is crucial to improving care and addressing hair loss concerns.

Bone Morphogenetic Proteins (BMPs) are important for hair growth, and their decrease due to hormones could lead to hair loss, but adding more BMPs could promote hair growth.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Hydrogel microneedles with special nanoparticles and growth factor improve hair growth better than minoxidil for hair loss treatment.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Ishophloroglucin A from Ishige okamurae may be a natural alternative for treating hair loss by inhibiting 5α-reductase and promoting hair growth.

Acetylsalicylic acid affects platelet-rich plasma activation, requiring personalized approaches for effective treatment.

Hair loss in adults is linked to heart disease risk factors like unhealthy blood fats, lack of exercise, and alcohol use. It's also slightly more common in people with metabolic syndrome. As people age, hair loss gets worse. In men, severe hair loss is tied to high blood pressure and a larger waist. In women, it's tied to higher body weight. People with hair loss should be checked for unhealthy blood fats and advised to avoid alcohol and inactivity.

SOD1 and KL are promising targets for new hair loss treatments.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

People with androgenetic alopecia are more likely to have metabolic syndrome.